Treating cystic fibrosis with mRNA therapy or CRISPR
(Mary Ann Liebert, Inc./Genetic Engineering News) The potential for treating cystic fibrosis (CF) using mRNA therapies or CRISPR gene editing is possible regardless of the causative mutation. CF clinical trials showing that a genotype-agnostic gene therapy for CF is possible
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: Clinical Trials | Cystic Fibrosis | Gene Therapy | Genetics | International Medicine & Public Health